Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment.

Nag, Sagorika; Mandal, Abhimanyu; Joshi, Aryaman; Jain, Neeraj; Srivastava, Ravi Shanker; Singh, Sanjay; Khattri, Arun

Nag, Sagorika; Mandal, Abhimanyu; Joshi, Aryaman; Jain, Neeraj; Srivastava, Ravi Shanker; Singh, Sanjay; Khattri, Arun.

Afiliación

Nag S; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Mandal A; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Joshi A; Department of Chemical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Jain N; Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow 226031, India.
Srivastava RS; Department of Pharmacology, Career Institute of Medical Sciences & Hospital, Lucknow 226020, India.
Singh S; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.
Khattri A; Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India.

Diseases ; 10(4)2022 Nov 28.

Article en En | MEDLINE | ID: mdl-36547200

Palabras clave

breast cancer; chemoresistance; inhibitors; neuraminidases; ovarian cancer; pancreatic cancer; sialyltransferases

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_ovary_cancer Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Revista: Diseases Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google